Daiken Medical Co., Ltd. (TYO:7775)

Daiken Medical Statistics

Total Valuation

Daiken Medical has a market cap or net worth of JPY 13.79 billion. The enterprise value is 13.26 billion.

Market Cap	13.79B
Enterprise Value	13.26B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Mar 30, 2026

Share Statistics

Daiken Medical has 28.73 million shares outstanding.

Current Share Class	28.73M
Shares Outstanding	28.73M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	48.78%
Owned by Institutions (%)	4.81%
Float	14.46M

Valuation Ratios

The trailing PE ratio is 14.05.

PE Ratio	14.05
Forward PE	n/a
PS Ratio	1.36
PB Ratio	1.79
P/TBV Ratio	1.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	13.51
EV / Sales	1.30
EV / EBITDA	n/a
EV / EBIT	10.11
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.24.

Current Ratio	2.40
Quick Ratio	1.82
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	118.47

Financial Efficiency

Return on equity (ROE) is 13.01% and return on invested capital (ROIC) is 13.94%.

Return on Equity (ROE)	13.01%
Return on Assets (ROA)	7.28%
Return on Invested Capital (ROIC)	13.94%
Return on Capital Employed (ROCE)	15.88%
Weighted Average Cost of Capital (WACC)	4.07%
Revenue Per Employee	56.48M
Profits Per Employee	5.45M
Employee Count	180
Asset Turnover	0.90
Inventory Turnover	4.56

Taxes

In the past 12 months, Daiken Medical has paid 323.62 million in taxes.

Income Tax	323.62M
Effective Tax Rate	24.80%

Stock Price Statistics

The stock price has decreased by -3.81% in the last 52 weeks. The beta is 0.06, so Daiken Medical's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	-3.81%
50-Day Moving Average	455.32
200-Day Moving Average	451.95
Relative Strength Index (RSI)	61.67
Average Volume (20 Days)	53,030

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daiken Medical had revenue of JPY 10.17 billion and earned 981.12 million in profits. Earnings per share was 34.15.

Revenue	10.17B
Gross Profit	3.94B
Operating Income	1.31B
Pretax Income	1.30B
Net Income	981.12M
EBITDA	n/a
EBIT	1.31B
Earnings Per Share (EPS)	34.15

Balance Sheet

The company has 2.38 billion in cash and 1.85 billion in debt, with a net cash position of 532.58 million or 18.54 per share.

Cash & Cash Equivalents	2.38B
Total Debt	1.85B
Net Cash	532.58M
Net Cash Per Share	18.54
Equity (Book Value)	7.70B
Book Value Per Share	267.89
Working Capital	3.98B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 38.79%, with operating and profit margins of 12.90% and 9.65%.

Gross Margin	38.79%
Operating Margin	12.90%
Pretax Margin	12.83%
Profit Margin	9.65%
EBITDA Margin	n/a
EBIT Margin	12.90%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 4.17%.

Dividend Per Share	20.00
Dividend Yield	4.17%
Dividend Growth (YoY)	-13.04%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	4.17%
Earnings Yield	7.11%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 13, 2014. It was a forward split with a ratio of 2.

Last Split Date	Nov 13, 2014
Split Type	Forward
Split Ratio	2

Scores

Daiken Medical has an Altman Z-Score of 5.16 and a Piotroski F-Score of 5.

Altman Z-Score	5.16
Piotroski F-Score	5